Generic name: LUMATEPERONE 42mg
Dosage form: capsule
Medically reviewed by Drugs.com. Last updated on Dec 27, 2019.
2.1 Recommended Dosage
The recommended dosage of CAPLYTA is 42 mg administered orally once daily with food. Dose titration is not required.
2.2 Dosage Recommendations for Concomitant Use with CYP3A4 Inducers and Moderate or Strong CYP3A4 Inhibitors
Coadministration with CYP3A4 Inducers
Avoid concomitant use of CAPLYTA with CYP3A4 inducers [see Drug Interactions (7.1)].
Coadministration with Moderate or Strong CYP3A4 Inhibitors
Avoid concomitant use of CAPLYTA with moderate or strong CYP3A4 inhibitors [see Drug Interactions (7.1)].
2.3 Dosage Recommendations for Patients with Hepatic Impairment
Avoid use of CAPLYTA in patients with moderate or severe hepatic impairment (Child-Pugh B or C) [see Use in Specific Populations (8.6)].
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Caplyta (lumateperone)
- Side Effects
- During Pregnancy
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 18 Reviews
- Drug class: atypical antipsychotics
- FDA Approval History